Scholars Central

Conference abstractPublished 24 Oct 2013

Evaluation of the yellow fever virus vaccine strain 14D as a new vector for HIV-1 vaccine development

Authors: Franco David

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

T he HIV-1 p24 sequence was inserted upstream of the YF 14D polyprotein or between the envelope protein (E) and the first nonstructural protein (NS1). In vitro characterization of these two chimeric constructs included Western blots, immunofluorescence studies, and assays to measure viral growth kinetics and plaque morphology. Humoral and cellular immune responses to p24 were assessed in mice immunized with each of the recombinant 14D or the unmodified vector. Comparison of RNA specific infectivity, viral titers, plaque morphologies and viral growth kinetics of the recombinant viruses with the parental YF 14D vaccine strain indicated that the HIV-1 p24 insert was well tolerated. HIV-1 p24 was readily detected by immunofluorescence and highly expressed, as assessed by Western blotting. Preliminary mouse immunogenicity experiments indicated that the YF 14D HIV-p24 recombinants were able to induce cellular and humoral immunity against the heterologous HIV-1 p24 antigen.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of AIDS & Clinical Research
  • SubjectInfectious Diseases
  • BylineArticles whose byline prints “Franco David”